Awards

• Proclamations from the California Legislature, Board Member CalHFA; Principal Author of CalHFA Legislation (2004)
• Time Magazine, The 2005 Time 100 (2005);
• Alliance for Aging Research, “Alan Cranston Living Legend Award” (2005);
• JDRF, Letter from Nancy Reagan (2005);
• JDRF, “Living and Giving Award” (2005);
• The Harvard Club, “Public Service Leader of the Year” (2006);
• The Commonwealth Club, “Distinguished Citizen Award” (2006);
• Proclamations from the California Legislature, “Conceptualizing, writing as principal consultant and managing legislation through signature to implementation under the direction of the State Legislature and Governor”, “Chair of Governing Board of the Independent Oversight Committee”; “Principal Negotiator and Member of Board of Directors for JDRF”; “Chair and Governing Board for California Institute for Regenerative Medicine”; “Board member for Housing Finance Agency” (2009);
• Research!America, “Gordon and Llura Gund Leadership Award” (2010);
• Biotechnology Industry Organization (BIO), “Biotech Humanitarian Award” (2010);
• Resolution of the Governing Board of the California Institute for Regenerative Medicine, Principal Drafter of Proposition 71 and First Chair of CIRM (2011);
• International Society for Stem Cell Research,  ISSCR Public Service Award (2011) (inaugural award);
• Board of Trustees of the California State University and Humboldt State University, honorary degree Doctor of Law (2012);

Boards (Non-Profit/Charitable Organizations)

• Bob Klein, for six years, was a Board Member of the Housing Finance Agency
• Bob Klein has also served on the Board of Genome Canada, a nonprofit research funding agency established by the Canadian federal and provincial governments with $1.8 billion in resources; this agency was originally focused on genomics research, principally in the medical field.
• Until June 23, 2011, Bob Klein served as the Chairman of the Governing Board of the California Institute of Regenerative Medicine (CIRM), the agency established by Proposition 71 to manage and distribute the $3 billion in stem cell research funding. He was elected Chairman Emeritus on that date.
• June 20, 2013, Bob Klein was appointed to the Board of Directors of the Ontario Institute of Cancer Research. OCIR is an innovative translational research institute dedicated to research on the prevention, early detection, diagnosis and treatment of cancer.

 

 

*Corporate Boards in the Housing & Urban Development field are available upon request.